DK1646378T3 - Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp - Google Patents

Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp

Info

Publication number
DK1646378T3
DK1646378T3 DK04739316T DK04739316T DK1646378T3 DK 1646378 T3 DK1646378 T3 DK 1646378T3 DK 04739316 T DK04739316 T DK 04739316T DK 04739316 T DK04739316 T DK 04739316T DK 1646378 T3 DK1646378 T3 DK 1646378T3
Authority
DK
Denmark
Prior art keywords
fungus
superinfection
relapsing
treatment
pharmaceutical compositions
Prior art date
Application number
DK04739316T
Other languages
Danish (da)
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Application granted granted Critical
Publication of DK1646378T3 publication Critical patent/DK1646378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
DK04739316T 2003-07-22 2004-05-21 Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp DK1646378T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077314A EP1500394A1 (de) 2003-07-22 2003-07-22 Pharmazeutische Zubereitungen enthaltende Ascorbinsäurederivate für die Behandlung von Pilzsuperinfektionen und den Wiederauftretens von Pilzinfektionen
PCT/EP2004/005559 WO2005013971A1 (en) 2003-07-22 2004-05-21 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences

Publications (1)

Publication Number Publication Date
DK1646378T3 true DK1646378T3 (da) 2009-01-19

Family

ID=33483977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04739316T DK1646378T3 (da) 2003-07-22 2004-05-21 Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp

Country Status (23)

Country Link
US (1) US7863326B2 (de)
EP (2) EP1500394A1 (de)
JP (1) JP4791358B2 (de)
KR (1) KR101100713B1 (de)
CN (1) CN100540000C (de)
AR (1) AR045070A1 (de)
AT (1) ATE413171T1 (de)
BR (1) BRPI0412453A (de)
CA (1) CA2528879A1 (de)
CY (1) CY1108684T1 (de)
DE (1) DE602004017613D1 (de)
DK (1) DK1646378T3 (de)
EA (1) EA010241B1 (de)
ES (1) ES2314406T3 (de)
HK (1) HK1092693A1 (de)
HR (1) HRP20090022T3 (de)
MX (1) MXPA05013798A (de)
PL (1) PL1646378T3 (de)
PT (1) PT1646378E (de)
SI (1) SI1646378T1 (de)
UA (1) UA88446C2 (de)
WO (1) WO2005013971A1 (de)
ZA (1) ZA200509851B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070293586A1 (en) * 2005-02-03 2007-12-20 Suresh Dixit Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
ES2477141B2 (es) * 2010-04-08 2015-02-23 University Of Florida Research Foundation, Inc. Sistema basado en un vector viral de expresión transitoria que permite múltiples aplicaciones
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
FR3018193B1 (fr) 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
US11865139B2 (en) * 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229430A (en) * 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
JPH01125306A (ja) * 1987-11-09 1989-05-17 Daiichi Seimo Kk 赤腐れ菌の防除剤
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5425944A (en) * 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
CN1245074A (zh) * 1998-04-26 2000-02-23 曾忠铭 减弱阴道酸度的药剂和用途
US6153635A (en) * 1998-11-20 2000-11-28 Upmalis; David H. Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
JP2000169370A (ja) * 1998-12-09 2000-06-20 Frontier:Kk 肉食動物用皮膚疾患治療薬及び健康食品
DE29900513U1 (de) * 1999-01-14 2000-08-10 RST Icking GmbH, 82057 Icking Schuh- bzw. Fuß-Hygienemittel
RU2150935C1 (ru) * 1999-06-22 2000-06-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
US6391330B1 (en) * 2000-05-11 2002-05-21 Michael A. Ross Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
US20030130225A1 (en) * 2001-10-16 2003-07-10 Nawaz Ahmad Novel methods of treating local fungal and bacterial infections

Also Published As

Publication number Publication date
HK1092693A1 (en) 2007-02-16
JP4791358B2 (ja) 2011-10-12
JP2006528138A (ja) 2006-12-14
ZA200509851B (en) 2007-03-28
PT1646378E (pt) 2008-12-17
SI1646378T1 (sl) 2009-02-28
MXPA05013798A (es) 2006-06-27
KR101100713B1 (ko) 2011-12-30
EP1646378B1 (de) 2008-11-05
KR20060040603A (ko) 2006-05-10
AR045070A1 (es) 2005-10-12
EP1646378A1 (de) 2006-04-19
HRP20090022T3 (en) 2009-02-28
ATE413171T1 (de) 2008-11-15
EP1500394A1 (de) 2005-01-26
DE602004017613D1 (de) 2008-12-18
EA200600176A1 (ru) 2006-06-30
CN100540000C (zh) 2009-09-16
CY1108684T1 (el) 2014-04-09
EA010241B1 (ru) 2008-06-30
WO2005013971A1 (en) 2005-02-17
PL1646378T3 (pl) 2009-04-30
US7863326B2 (en) 2011-01-04
BRPI0412453A (pt) 2006-10-17
ES2314406T3 (es) 2009-03-16
UA88446C2 (uk) 2009-10-26
CN1812781A (zh) 2006-08-02
CA2528879A1 (en) 2005-02-17
US20070037880A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
DK1679058T3 (da) Farmaceutisk sammensætning til behandling af kardiovaskulære og cerebrovaskulære sygdomme
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
DK1620429T3 (da) Nye heterocykliske forbindelser anvendelige til behandling af inflammatoriske og allergiske sygdomme, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende disse
DE602005005456D1 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
NO20050569D0 (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1638589T3 (da) Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
NO20053874D0 (no) Formulering og metoder for behandling av thrombocytemi
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
DK1750713T3 (da) Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner
DE602005015486D1 (de) Esterderivate von ascorbinsäure und 2-ketosäuresacchariden
DK1617834T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende mælkesyre eller lactat og kalium til behandling af hjerneödem eller hjerneskade
DK1635791T3 (da) Farmaceutisk komposition omfattende atorvastatin og fremstillet uden granulering
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
DK1848440T3 (da) Farmaceutisk sammensætning og fremgangsmåde til regenerering af myofibre i behandlingen af muskelskader
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.